Abstract
Agitation is a major healthcare issue seen frequently in emergency and acute care settings and can be potentially harmful to patients, families, caregivers, and healthcare staff. Until recently, most interventions for agitation have focused on involuntary, forcibly injected medications for heavy sedation, and placement of affected individuals into physical restraints. Modern expert consensus, however, recommends a less coercive approach to quell agitation – using verbal de-escalation and other calming techniques, and voluntarily accepted medications – if this can be done safely. In this contemporary philosophy, restraints and forcible medications instead should be reserved only for those situations in which non-coercive alternatives have been exhausted. The major initial goals of agitation care should include the exclusion of severe medical etiologies for symptoms, and an empathetic, rapid stabilization of the acute crisis and distress, while longer-term interventions include creating a therapeutic alliance and effective continuing care to help prevent future episodes. This chapter details preferred methods of both the medical and psychiatric evaluations of agitation, as well as a comprehensive guide to de-escalation techniques, and describes current consensus best practice guidelines on psychopharmacologic approaches. In addition, there are sections on the pathophysiology of agitation, proper utilization (and avoidance when possible) of locked seclusion and physical restraints, agitation measurement scales, and important research findings and metrics related to the evaluation and treatment of agitated individuals.
References
Administration TSAaMHS. (2003). Summary report: A national call to action: eliminating the use of seclusion and restraint.
Allen, M. H. (2007). The organization of psychiatric emergency services and related differences in restraint practices. General Hospital Psychiatry, 29(6), 467–469.
Allen, M. H., Carpenter, D., Sheets, J. L., Miccio, S., & Ross, R. (2003). What do consumers say they want and need during a psychiatric emergency? Journal of Psychiatric Practice, 9(1), 39–58.
Allen, M. H., Currier, G. W., Carpenter, D., Ross, R. W., Docherty, J. P., & Expert Consensus Panel for Behavioral E. (2005). The expert consensus guideline series. Treatment of behavioral emergencies 2005. Journal of Psychiatric Practice, 11(Suppl 1), 5–108; quiz 10–2.
Annas, G. J. (1999). The last resort – The use of physical restraints in medical emergencies. The New England Journal of Medicine, 341(18), 1408–1412.
Barrett, J. A., Edinger, H., & Siegel, A. (1990). Intrahypothalamic injections of norepinephrine facilitate feline affective aggression via alpha 2-adrenoceptors. Brain Research, 525(2), 285–293.
Battaglia, J. (2005). Pharmacologic management of acute agitation. Drugs, 65, 1207–1222.
Beach, S. R., Celano, C. M., Sugrue, A. M., Adams, C., Ackerman, M. J., Noseworthy, P. A., et al. (2018). QT prolongation, Torsades de Pointes, and psychotropic medications: A 5-year update. Psychosomatics, 59(2), 105–122.
Belkin, G. S. (2002). Self-restraint, self-examination: A historical perspective on restraints and ethics in psychiatry. Psychiatric Services, 53(6), 663–664.
Berridge, C. W. (2008). Noradrenergic modulation of arousal. Brain Research Reviews, 58(1), 1–17.
Berzlanovich, A. M., Schopfer, J., & Keil, W. (2012). Deaths due to physical restraint. Deutsches Arzteblatt International, 109, 27–32.
Camm, A. J. (2012). Ziprasidone and the corrected QT interval: A comprehensive summary of clinical data. CNS Drugs, 26(4), 351–65.
Campillo, A., Castillo, E., Vilke, G. M., Hopper, A., Ryan, V., & Wilson, M. P. (2015). First-generation antipsychotics are often prescribed in the emergency department but are often not administered with adjunctive medications. The Journal of Emergency Medicine, 49(6), 901–906.
Cañas, F. (2007). Management of agitation in the acute psychotic patient – Efficacy without excessive sedation. European Neuropsychopharmacology, 17, S108–S114.
Caracci, G., & Ananthamoorthy, R. (1999). Prolactin levels in premenopausal women treated with risperidone compared with those of women treated with typical neuroleptics. Journal of Clinical Psychopharmacology, 19, 194–196.
Carmel, H., & Hunter, M. (1989). Staff injuries from inpatient violence. Hospital & Community Psychiatry, 40(1), 41–46.
Citrome, L. (2011). Role of sublingual asenapine in treatment of schizophrenia. Neuropsychiatric Disease and Treatment, 7, 325–339.
Citrome, L., & Volavka, J. (1999). Violent patients in the emergency setting. The Psychiatric Clinics of North America, 22(4), 789–801.
Citrome, L., Landbloom, R., Chang, C. T., & Earley, W. (2017). Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder. Neuropsychiatric Disease and Treatment, 13, 2955–2963.
Cole, J. B., Klein, L. R., Mullinax, S. Z., Nordstrom, K. D., Driver, B. E., & Wilson, M. P. (2019). Study enrollment when “Preconsent” is utilized for a randomized clinical trial of two treatments for acute agitation in the Emergency Department. Academic Emergency Medicine, 26(5), 559–566.
Cuomo, A., Beccarini Crescenzi, B., Goracci, A., Bolognesi, S., Giordano, N., Rossi, R., et al. (2019). Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety, 18(6), 455–463.
Currier, G. W., Chou, J. C., Feifel, D., Bossie, C. A., Turkoz, I., Mahmoud, R. A., et al. (2004). Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. The Journal of Clinical Psychiatry, 65(3), 386–394.
Currier, G. W., Trenton, A. J., Walsh, P. G., & van Wijngaarden, E. (2006). A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting. Journal of Psychiatric Practice, 12(4), 223–228.
Currier, G. W., Walsh, P., & Lawrence, D. (2011). Physical restraints in the emergency department and attendance at subsequent outpatient psychiatric treatment. Journal of Psychiatric Practice, 17(6), 387–393.
Day, R. K. (1999). Psychomotor agitation: poorly defined and badly measured. Journal of Affective Disorders, 55, 89–98.
De Berardis, D., Fornaro, M., Orsolini, L., Iasevoli, F., Tomasetti, C., de Bartolomeis, A., et al. (2017). The role of inhaled Loxapine in the treatment of acute agitation in patients with psychiatric disorders: A clinical review. International Journal of Molecular Sciences, 18(2), 349.
Department of Health and Human Services. (2006). Condition of participation: patient’s rights. Federal Register, 482(13), 71426–71428.
Dolder, C. R., & Jeste, D. V. (2003). Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biological Psychiatry, 53(12), 1142–1145.
Duhart, D. T. (2001). Violence in the workplace, 1993–99. Publication No. NCJ 190076. US Department of Justice Programs.
Elgin, S. H. (1999). Language in emergency medicine: A verbal self-defense handbook. XLibris Corporation.
Fishkind, A. (2002). Calming agitation with words, not drugs: 10 commandments for safety. Current Psychiatry, 1, 32–39. Available at: http://www.currentpsychiatry.com/pdf/0104/0104_Fishkind.pdf. Accessed June 13, 2011.
Fishkind, A. (2008). Agitation II: De-escalation of the aggressive patient and avoiding coercion. In R. L. Glick, J. S. Berlin, A. B. Fishkind, et al. (Eds.), Emergency psychiatry: Principles and practice. Wolters Kluwer Health/Lippincott Williams & Wilkins.
Forster, P. L., Cavness, C., & Phelps, M. A. (1999). Staff training decreases use of seclusion and restraint in an acute psychiatric hospital. Archives of Psychiatric Nursing, 13, 269–271.
Frueh, B. C., Knapp, R. G., & Cusack, K. J. (2005). Patient’s reports of traumatic or harmful experiences within the psychiatric setting. Psychiatric Services, 56, 1123–1133.
Garriga, M., Pacchiarotti, I., Kasper, S., Zeller, S. L., Allen, M. H., Vazquez, G., et al. (2016). Assessment and management of agitation in psychiatry: expert consensus. The World Journal of Biological Psychiatry, 17(2), 86–128.
Gates, D. M., Ross, C. S., & McQueen, L. (2006). Violence against emergency department workers. The Journal of Emergency Medicine, 31(3), 331–337.
Gault, T. I., Gray, S. M., Vilke, G. M., & Wilson, M. P. (2012). Are oral medications effective in the management of acute agitation? The Journal of Emergency Medicine, 43(5), 854–859.
Gaynes, B. N., Brown, C. L., Lux, L. J., Brownley, K. A., Van Dorn, R. A., Edlund, M. J., et al. (2017). Preventing and de-escalating aggressive behavior among adult psychiatric patients: a systematic review of the evidence. Psychiatric Services, 68(8), 819–831.
Gerlach, J., & Larsen, E. B. (1999). Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatrica Scandinavica, 99, 113–117.
Gordon, H., Hindley, N., Marsden, A., & Shivayogi, M. (1999). The use of mechanical restraint in the management of psychiatric patients: Is it ever appropriate? The Journal of Forensic Psychiatry, 10(1), 173–186.
Haimowitz, S., Urff, J., & Huckshorn, K. A. (2006). Restraint and seclusion – A risk management guide. National Association of State Mental Health Program Directors Web site. Available from: http://www.nasmhpd.org/docs/publications/docs/2008/SRBriefings/I_3_I_B_MngtGuideAttorneys.pdf.
Hall, R. C., Gardner, E. R., Popkin, M. K., Lecann, A. F., & Stickney, S. K. (1981). Unrecognized physical illness prompting psychiatric admission: A prospective study. The American Journal of Psychiatry, 138(5), 629–635.
Holloman, G. H., Jr., & Zeller, S. L. (2012). Overview of project BETA: Best practices in evaluation and treatment of agitation. The Western Journal of Emergency Medicine, 13(1), 1–2.
Howes, O. D., & Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III – the final common pathway. Schizophrenia Bulletin, 35(3), 549–562.
Huf, G., Coutinho, E. S., Adams, C. E., & Group TC. (2007). Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine. BMJ, 335(7625), 869.
Huf, G., Alexander, J., Allen, M. H., & Raveendran, N. S. (2009). Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database of Systematic Reviews, 3, Art. No.: CD005146.
Keck, P. E., & McElroy, S. L. (2002). Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications. The Journal of Clinical Psychiatry, 63(suppl 4), 3–11.
Kinon, B. J., Gilmore, J. A., Liu, H., & Halbreich, U. M. (2003). Hyperprolactinemia in response to antipsychotic drugs: Characterization across comparative clinical trials. Psychoneuroendocrinology, 28(Suppl 2), 69–82.
Knox, D. K., & Holloman, G. H. (2012). Use and avoidance of seclusion and restraint: consensus statement of the American Association for Emergency Psychiatry Project BETA seclusion and restraint workgroup. The Western Journal of Emergency Medicine, 13(1), 35–40.
Lam, L. T. (2002). Aggression exposure and mental health among nurses. Australian e-Journal for the Advances Mental Health, 1, 89–100.
Lazare, A., & Levy, R. S. (2011). Apologizing for humiliations in medical practice. Chest, 139(4), 746–751.
Lesem, M. D., Tran-Johnson, T. K., Riesenberg, R. A., Feifel, D., Allen, M. H., Fishman, R., et al. (2011). Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. The British Journal of Psychiatry, 198(1), 51–58.
Lindenmayer, J. P. (2000). The pathophysiology of agitation. The Journal of Clinical Psychiatry, 61(suppl 14), 5–10.
MacDonald, K., Wilson, M. P., Minassian, A., Vilke, G. M., Perez, R., Cobb, P., et al. (2010). A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients. General Hospital Psychiatry, 32(4), 443–445.
MacDonald, K., Wilson, M., Minassian, A., Vilke, G. M., Becker, O., Tallian, K., et al. (2012). A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation. Journal of Clinical Psychopharmacology, 32(3), 317–322.
Mallikaarjun, S., Shoaf, S. E., Boulton, D. W., & Bramer, S. L. (2008). Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole. Clinical Pharmacokinetics, 47(8), 533–542.
Martinez-Raga, J., Amore, M., Di Sciascio, G., Florea, R. I., Garriga, M., Gonzalez, G., et al. (2018). 1st international experts’ meeting on agitation: conclusions regarding the current and ideal management paradigm of agitation. Frontiers in Psychiatry, 9, 54.
McCue, R. E., Urcuyo, L., & Lilu, Y. (2004). Reducing restraint use in a public psychiatric inpatient service. The Journal of Behavioral Health Services & Research, 31, 217–224.
Miner, J. R., Klein, L. R., Cole, J. B., Driver, B. E., Moore, J. C., & Ho, J. D. (2018). The characteristics and prevalence of agitation in an Urban County Emergency Department. Annals of Emergency Medicine, 72(4), 361–370.
Mullinax, S., Shokraneh, F., Wilson, M. P., & Adams, C. E. (2017). Oral medication for agitation of psychiatric origin: A scoping review of randomized controlled trials. The Journal of Emergency Medicine, 53(4), 524–529.
Nordstrom, K. (2009). Inhaled loxapine for acute agitation. Future Neurology, 4, 539–545.
Nordstrom, K., & Allen, M. H. (2007). Managing the acutely agitated and psychotic patient. CNS Spectrums, 12(10 Suppl 17), 5–11.
Nordstrom, K., & Wilson, M. P. (Eds.). (2018). Quick guide to psychiatric emergencies: Tools for behavioral and toxicological situations. Springer International Publishing.
Nordstrom, K., Zun, L. S., Wilson, M. P., Stiebel, V., Ng, A. T., Bregman, B., et al. (2012). Medical evaluation and triage of the agitated patient: consensus statement of the American Association for emergency psychiatry project beta medical evaluation workgroup. The Western Journal of Emergency Medicine, 13(1), 3–10.
Ostinelli, E. G., Brooke-Powney, M. J., Li, X., & Adams, C. E. (2017). Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database of Systematic Reviews, 7, CD009377.
Ostinelli, E. G., Jajawi, S., Spyridi, S., Sayal, K., & Jayaram, M. B. (2018). Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database of Systematic Reviews, 1, CD008074.
Pacciardi, B., Calcedo, A., & Messer, T. (2019). Inhaled Loxapine for the management of acute agitation in bipolar disorder and schizophrenia: Expert review and commentary in an era of change. Drugs R D., 19(1), 15–25.
Polcwiartek, C., Sneider, B., Graff, C., Taylor, D., Meyer, J., Kanters, J. K., et al. (2015). The cardiac safety of aripiprazole treatment in patients at high risk for torsade: A systematic review with a meta-analytic approach. Psychopharmacology, 232(18), 3297–3308.
Powney, M. J., Adams, C. E., & Jones, H. (2012). Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database of Systematic Reviews, 11, CD009377.
Pratts, M., Citrome, L., Grant, W., Leso, L., & Opler, L. A. (2014). A single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitation. Acta Psychiatrica Scandinavica, 130(1), 61–68.
Preval, H., Klotz, S. G., Southard, R., & Francis, A. (2005). Rapid-acting IM ziprasidone in a psychiatric emergency service: A naturalistic study. General Hospital Psychiatry, 27(2), 140–144.
Rappaport, B. A. (2008). FDA response to droperidol black box warning editorials. Anesthesia and Analgesia, 106, 1585.
Raveendran, N. S., Tharyan, P., Alexander, J., Adams, C. E., & Group TR-IIC. (2007). Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ, 335(7625), 865.
Recupero, P. R., Price, M., Garvey, K. A., Daly, B., & Xavier, S. L. (2011). Restraint and seclusion in psychiatric treatment settings: regulation, case law, and risk management. The Journal of the American Academy of Psychiatry and the Law, 39, 465–476.
Richards, J. R., & Schneir, A. B. (2003). Droperidol in the Emergency Department: Is it safe? The Journal of Emergency Medicine, 24(4), 441–447.
Richmond, J. S., Berlin, J. S., Fishkind, A. B., Holloman, G. H., Jr., Zeller, S. L., Wilson, M. P., et al. (2012). Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA de-escalation workgroup. The Western Journal of Emergency Medicine, 13(1), 17–25.
Ries, R., & Sayadipour, A. (2014). Management of psychosis and agitation in medical-surgical patients who have or are at risk for prolonged QT interval. Journal of Psychiatric Practice, 20(5), 338–344.
Rogers, C. R. (1957). The necessary and sufficient conditions of therapeutic personality change. Journal of Consulting Psychology, 21(2), 95–103.
Sacchetti, E., Amore, M., Di Sciascio, G., Ducci, G., Girardi, P., Mauri, M., et al. (2017). Psychomotor agitation in psychiatry: an Italian expert consensus. Evidence-Based Psychiatric Care, 1, 1–24.
Sachs, G. S. (2006). A review of agitation in mental illness: burden of illness and underlying pathology. The Journal of Clinical Psychiatry, 67(Suppl 10), 5–12.
San, L., Marksteiner, J., Zwanzger, P., Figuero, M. A., Romero, F. T., Kyropoulos, G., et al. (2016). State of acute agitation at psychiatric emergencies in Europe: the STAGE study. Clinical Practice and Epidemiology in Mental Health, 12, 75–86.
Schneider, A., Mullinax, S., Hall, N., Acheson, A., Oliveto, A., & Wilson, M. P. (2021 Aug). Intramuscular agitation for treatment of agitation in the emergency department: A systematic review of controlled trials. The American Journal of Emergency Medicine, 46, 193–199.
Siegel, A., Roeling, T. A., Gregg, T. R., & Kruk, M. R. (1999). Neuropharmacology of brain-stimulation-evoked aggression. Neuroscience and Biobehavioral Reviews, 23(3), 359–389.
Smith, M. J. (1975). When I Say No, I Feel Guilty: How To Cope – Using the skills of systematic assertive therapy. Dial Press/Bantum Books.
Smith, G. M., Davis, R. H., Bixler, E. O., Lin, H. M., Altenor, A., Altenor, R. J., et al. (2005). Pennsylvania State Hospital system’s seclusion and restraint reduction program. Psychiatric Services, 56(9), 1115–1122.
Smith, G. M., Ashbridge, D. M., Davis, R. H., & Steinmetz, W. (2015). Correlation between reduction of seclusion and restraint and assaults by patients in Pennsylvania’s state hospitals. Psychiatric Services, 66(3), 303–309.
Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., et al. (2017). Safety, tolerability, and risks associated with first- and second-generation antipsychotics: A state-of-the-art clinical review. Therapeutics and Clinical Risk Management, 13, 757–777.
Stowell, K. R., Florence, P., Harman, H. J., & Glick, R. L. (2012). Psychiatric evaluation of the agitated patient: Consensus statement of the American Association for emergency psychiatry project beta psychiatric evaluation workgroup. The Western Journal of Emergency Medicine, 13(1), 11–16.
Swift, R. H., Harrigan, E. P., Cappelleri, J. C., Kramer, D., & Chandler, L. P. (2002). Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients. Journal of Psychiatric Research, 36(2), 87–95.
Vieta, E., & Montes, J. M. (2018). A review of asenapine in the treatment of bipolar disorder. Clinical Drug Investigation, 38(2), 87–99.
Vieta, E., Garriga, M., Cardete, L., Bernardo, M., Lombrana, M., Blanch, J., et al. (2017). Protocol for the management of psychiatric patients with psychomotor agitation. BMC Psychiatry, 17(1), 328.
Vilke, G. M., Bozeman, W. P., Dawes, D. M., Demers, G., & Wilson, M. P. (2012). Excited delirium syndrome (ExDS): treatment options and considerations. Journal of Forensic and Legal Medicine, 19(3), 117–121.
Williams, A. M. (2018). Coadministration of intramuscular olanzapine and benzodiazepines in agitated patients with mental illness. Mental Health Clinic, 8(5), 208–213.
Wilson, M. P. (2019). Acute agitation. In J. E. Tintinalli, O. J. Ma, D. Yealy, G. D. Meckler, & J. S. Stapyczynski (Eds.), Tintinalli’s emergency medicine: A comprehensive study guide (9th ed.). McGraw Hill.
Wilson, M. P., & Sloane, C. (2012). Chemical restraints, physical restraints, and other demonstrations of force. In J. Jesus, P. Rosen, J. Adams, A. Derse, R. Wolfe, & S. Grossman (Eds.), Ethical problems in emergency medicine: A discussion-based review (pp. 139–148). Wiley-Blackwell.
Wilson, M. P., Pepper, D., Currier, G. W., Holloman, G. H., Jr., & Feifel, D. (2012a). The psychopharmacology of agitation: consensus statement of the American Association for emergency psychiatry project beta psychopharmacology workgroup. The Western Journal of Emergency Medicine, 13(1), 26–34.
Wilson, M. P., Chen, N., Vilke, G. M., Castillo, E. M., MacDonald, K. S., & Minassian, A. (2012b). Olanzapine in ED patients: Differential effects on oxygenation in patients with alcohol intoxication. The American Journal of Emergency Medicine, 30(7), 1196–1201.
Wilson, M. P., MacDonald, K., Vilke, G. M., & Feifel, D. (2012c). Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients. The Journal of Emergency Medicine, 43(5), 889–896.
Wilson, M. P., MacDonald, K., Vilke, G. M., & Feifel, D. (2012d). A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation. The Journal of Emergency Medicine, 43(5), 790–797.
Wilson, M. P., MacDonald, K., Vilke, G. M., Ronquillo, L., & Feifel, D. (2013). Intramuscular ziprasidone: Influence of alcohol and benzodiazepines on vital signs in the emergency setting. The Journal of Emergency Medicine, 45(6), 901–908.
Wilson, M. P., Nordstrom, K., Shah, A. A., & Vilke, G. M. (2015). Psychiatric emergencies in pregnant women. Emergency Medicine Clinics of North America, 33(4), 841–851.
Wilson, M. P., Nordstrom, K., Hopper, A., Porter, A., Castillo, E. M., & Vilke, G. M. (2017). Risperidone in the emergency setting is associated with more hypotension in elderly patients. The Journal of Emergency Medicine, 53(5), 735–739.
Zareifopoulos, N., & Panayiotakopoulos, G. (2019). Treatment Options for Acute Agitation in Psychiatric Patients: Theoretical and Empirical Evidence. Cureus, 11(11), e6152.
Zeller, S. L. (2010). Treatment of psychiatric patients in emergency settings. Primary Psychiatry, 17, 35–41.
Zeller, S. L., & Rhoades, R. W. (2010). Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clinical Therapeutics, 32(3), 403–425.
Zeller, S. L., & Wilson, M. P. (2011). Acute treatment of agitation in schizophrenia. Drug Discovery Today: Therapeutic Strategies., 8(1–2), 25–29.
Zeller, S. L., Holloman, G. H., & Wilson, M. P. (2014). Management of agitation. In A. Tasman, J. Lieberman, J. Kay, M. First, & M. Riba (Eds.), Psychiatry (4th ed.). Wiley Publishing.
Zeller, S. L., Nordstrom, K. D., & Wilson, M. P. (2017). The diagnosis and management of agitation. Cambridge, 281 p.
Zun, L. S. (2003). A prospective study of the complication rate of use of patient restraint in the emergency department. The Journal of Emergency Medicine, 24(2), 119–124.
Zun, L. S. (2018). Evidence-based review of pharmacotherapy for acute agitation. Part 1: Onset of efficacy. The Journal of Emergency Medicine, 54(3), 364–374.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Zeller, S.L., Wilson, M.P., Pacciardi, B. (2023). Assessment and Management of Agitation. In: Tasman, A., et al. Tasman’s Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-42825-9_5-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-42825-9_5-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42825-9
Online ISBN: 978-3-030-42825-9
eBook Packages: Springer Reference MedicineReference Module Medicine